Phathom Pharmaceuticals logo

Phathom Pharmaceuticals Share Price (NASDAQ: PHAT)

$12.19

-0.17

(-1.38%)

Last updated on

Check the interactive Phathom Pharmaceuticals Stock chart to analyse performance

Phathom Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$11.84
    Today's High:$12.24

    Day's Volatility :3.27%

  • 52 Weeks Low:$2.21
    52 Weeks High:$19.71

    52 Weeks Volatility :88.79%

Phathom Pharmaceuticals Stock Returns

PeriodPhathom Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
163.15%
3.6%
0.0%
6 Months
134.36%
-7.7%
0.0%
1 Year
-24.82%
-12.6%
0.0%
3 Years
39.7%
9.5%
-4.7%

Phathom Pharmaceuticals Inc Key Stats

Check Phathom Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$12.36
Open
$12.09
Today's High
$12.24
Today's Low
$11.84
Market Capitalization
$882.5M
Today's Volume
$600.4K
52 Week High
$19.71
52 Week Low
$2.21
Revenue TTM
$114.0M
EBITDA
$-268.3M
Earnings Per Share (EPS)
$-4.67
Profit Margin
-289.51%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3489.0%

Stock Returns calculator for Phathom Pharmaceuticals Stock including INR - Dollar returns

The Phathom Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Phathom Pharmaceuticals investment value today

Current value as on today

₹79,073

Returns

₹20,927

(-20.93%)

Returns from Phathom Pharmaceuticals Stock

₹26,211 (-26.21%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Phathom Pharmaceuticals Stock

117%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Phathom Pharmaceuticals Stock from India on INDmoney has increased by 117% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Phathom Pharmaceuticals Inc

  • Name

    Holdings %

  • Medicxi Ventures Management (Jersey) Ltd

    10.65%

  • Amvescap Plc.

    5.21%

  • The Carlyle Group Inc

    4.99%

  • BlackRock Inc

    4.74%

  • Vanguard Group Inc

    3.98%

  • Ensign Peak Advisors Inc

    3.59%

Analyst Recommendation on Phathom Pharmaceuticals Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Phathom Pharmaceuticals(by analysts ranked 0 to 5 stars)

Phathom Pharmaceuticals Share Price Target

What analysts predicted

Upside of 75.35%

Target:

$21.38

Current:

$12.19

Phathom Pharmaceuticals share price target is $21.38, a slight Upside of 75.35% compared to current price of $12.19 as per analysts' prediction.

Phathom Pharmaceuticals Stock Insights

  • Price Movement

    In the last 1 month, PHAT stock has moved up by 40.2%
  • PHAT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 96.0%
  • PHAT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 68.8%
  • Price to Sales

    ForPHAT every $1 of sales, investors are willing to pay $7.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Phathom Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Phathom Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Phathom Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Phathom Pharmaceuticals Inc logo
42.97%
134.36%
-24.82%
39.7%
-65.0%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Organization
Phathom Pharmaceuticals
Employees
427
CEO
Mr. Steven L. Basta M.B.A.
Industry
Health Technology

Key Management of Phathom Pharmaceuticals Inc

NameTitle
Mr. David A. Socks
Co-Founder
Dr. Azmi Nabulsi M.D., M.P.H.
Co-Founder
Mr. Steven L. Basta M.B.A.
CEO, President & Director
Mr. Robert Breedlove
VP of Finance & Principal Accounting Officer
Mr. Jonathan Bentley
Senior VP and Head of Sales, Operations & Training
Mr. Bill Aprea J.D.
Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer
Ms. Anne Marie Cook Esq., J.D.
Chief Legal Officer & Corporate Secretary
Ms. Susan Kim
Senior Vice President of Marketing
Mr. Paul Cocja
Chief People Officer
Dr. Eckhard Leifke M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in PHAT Stock from India :

What is Phathom Pharmaceuticals share price today?

Phathom Pharmaceuticals share price today is $12.19 as on at the close of the market. Phathom Pharmaceuticals share today touched a day high of $12.24 and a low of $11.84.

What is the 52 week high and 52 week low for Phathom Pharmaceuticals share?

Phathom Pharmaceuticals share touched a 52 week high of $19.71 and a 52 week low of $2.21. Phathom Pharmaceuticals stock price today i.e. is closed at $12.19, lower by 38.15% versus the 52 week high.

How to invest in Phathom Pharmaceuticals Stock (PHAT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Phathom Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phathom Pharmaceuticals Shares that will get you 0.1231 shares as per Phathom Pharmaceuticals share price of $12.19 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Phathom Pharmaceuticals Stock (PHAT) from India?

Indian investors can start investing in Phathom Pharmaceuticals (PHAT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Phathom Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Phathom Pharmaceuticals share’s latest price of $12.19 as on August 30, 2025 at 1:29 am IST, you will get 0.8203 shares of Phathom Pharmaceuticals. Learn more about fractional shares .

What are the returns that Phathom Pharmaceuticals has given to Indian investors in the last 5 years?

Phathom Pharmaceuticals stock has given -65.0% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?